Please check your internet connection and try again.
# Hyaluronic Acid
## Overview
Hyaluronic acid (HA) is a naturally occurring polysaccharide found in various tissues, including synovial fluid, skin, and connective tissue. It acts as a lubricant and shock absorber. Pharmaceutical preparations are typically synthetic or derived from bacterial fermentation.
## Primary Indications
* **Intra-articular injection:** Osteoarthritis of the knee (pain relief).
* **Ophthalmic solution:** Ocular lubrication for dry eye symptoms.
* **Topical preparations:** Skin moisturization and wound healing.
* **Surgical adjunct:** Viscosurgical device in ophthalmic surgery (e.g., cataract surgery).
## Adult Dosing
* **Intra-articular for Knee Osteoarthritis:** Varies by product. Commonly:
* 2 mL or 2.5 mL (20 mg or 25 mg) injected intra-articularly once weekly for 3-5 weeks.
* Some formulations allow for a single injection of 6 mL (60 mg).
* Maximum frequency and total number of injections depend on the specific product and clinical response. Follow product labeling or local protocol.
* **Ophthalmic Solution:** Typically 1 drop instilled into the eye as needed, up to several times daily.
* **Topical Preparations:** Apply as directed by the product or healthcare provider.
* **Surgical Adjunct (Ophthalmic):** Used during surgery as per surgical technique and product guidelines.
## Pediatric Dosing
* **Intra-articular for Knee Osteoarthritis:** Not typically recommended or studied in pediatric populations.
* **Ophthalmic Solution:** Generally considered safe for use in children as needed for dry eye symptoms, similar to adults. Consult product labeling for specific age recommendations.
* **Topical Preparations:** Generally considered safe for use in children.
## Dose Adjustments
No specific dose adjustments are typically required for renal or hepatic impairment, as systemic absorption is minimal for topical and intra-articular formulations.
## Contraindications
* Known hypersensitivity to hyaluronic acid or any component of the formulation.
* Active infection at or near the injection site for intra-articular preparations.
* Skin infection over the injection area for intra-articular preparations.
## Adverse Effects
* **Intra-articular:** Pain, swelling, stiffness, warmth, or redness at the injection site. Transient joint effusion.
* **Ophthalmic:** Temporary blurred vision, eye irritation, stinging, or burning.
* **Topical:** Skin irritation, redness.
## Key Drug Interactions
* **Intra-articular:** Avoid concomitant use of disinfectants containing quaternary ammonium salts, as they may precipitate hyaluronic acid. Concurrent intra-articular corticosteroids may increase the risk of infection or joint damage, though this is debated and often managed by timing.
* **Ophthalmic:** May potentially affect the absorption or efficacy of other topical ophthalmic medications. Separate administration by at least 5 minutes.
## Monitoring
* **Intra-articular:** Monitor for injection site reactions, joint effusion, and relief of pain and improved function.
* **Ophthalmic:** Monitor for relief of dry eye symptoms and ocular irritation.
## Clinical Pearls
* Hyaluronic acid is a viscoelastic fluid that can provide lubrication and cushioning.
* For intra-articular use, proper injection technique is crucial to minimize adverse events.
* Effectiveness for knee osteoarthritis may be delayed and is often dose- and product-dependent. Multiple treatment cycles may be needed.
* For ophthalmic use, preservative-free formulations are preferred for frequent use to minimize ocular surface toxicity.
***
**Disclaimer:** This information is intended for clinical use and does not substitute for professional medical advice. Always consult the most current prescribing information, product monographs, and institutional protocols before making any treatment decisions.
